NEW YORK (GenomeWeb News) - The National Cancer Institute has purchased site-wide licenses to Partek’s Genomic Suite, the company announced today.
 
The suite is a statistical and visual data analysis software package that can handle thousands of samples and millions of variables in a genomics experiment, according to Partek.
 
Financial terms of the deal were not released.
 
Every researcher at NCI will have access to the suite as a result of the transaction, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.